NLRP3 and obesity disorder: Notably, obesity-induced VAT NLRP3 inflammasome activation is reported to mediate neuroinflammation and subsequent cognitive decline via activation of the microglial interleukin-1 receptor 1 (IL-1R1) (Guo et al., 2020).